Key facts
- This page summarizes Nick Leschly's Form 4 filing for bluebird bio, Inc. (BLUE).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 08 Nov 2024, 16:09.
Nick Leschly - 06 Nov 2024 Form 4 Insider Report for bluebird bio, Inc. (BLUE)
- Reporting relationship
- Director
- Issuer ticker
- BLUE
- Reported as of
- 06 Nov 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 08 Nov 2024, 16:09:06 UTC
- Prior SEC filing
- 09 Jan 2024
- Next SEC filing
- 07 Jan 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Sydney Gaylin, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Nick Leschly filed Form 4 for bluebird bio, Inc. (BLUE) on 08 Nov 2024.
Change
- Previous filing in this sequence was filed on 09 Jan 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BLUE
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +24,900
- Change %
- +8.6%
- Price
- $0.000000
- Shares after
- 315,839
- Date
- 06 Nov 2024
- Ownership
- Direct
- Footnotes
- F1
BLUE
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 45,699
- Date
- 06 Nov 2024
- Ownership
- Nick Leschly 2001 Trust
BLUE
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 123,000
- Date
- 06 Nov 2024
- Ownership
- Nick Leschly Irrevocable GST Trust of 2019
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
BLUE
transaction
Derivative
Stock Option (right to buy)
Award
- Transaction value
- $0
- Shares
- +49,850
- Change %
- Price
- $0.000000
- Shares after
- 49,850
- Date
- 06 Nov 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 49,850
- Exercise price
- $0.4400
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
These restricted stock units for common stock vest 100% on the earlier of November 6, 2025 or the date of the next annual meeting of stockholders.
Footnote F2
This option vests 100% on the earlier of November 6, 2025 or the date of the next annual meeting of stockholders.